Cholesterol Balance Score (Production/Absorption)

High Cholesterol Balance Score – Interpretation

(An absorption-dominant pattern)

A high Cholesterol Balance Score indicates higher intestinal cholesterol absorption than internal production. This “hyper-absorber” phenotype means your body pulls in more cholesterol—and plant sterols—from the digestive tract, contributing to higher LDL levels. Individuals with a high score typically benefit most from therapies that block cholesterol absorption, especially ezetimibe, soluble fiber, and plant sterols/stanols. Dietary patterns (higher saturated fats, low fiber) may worsen absorption, while gut-targeted strategies can improve it. In some cases, genetic sterol transport variants can contribute. Tracking your score over time helps evaluate how effectively treatment is reducing absorption.

A low Cholesterol Balance Score on the Boston Heart Cholesterol Balance® test indicates that cholesterol absorption is higher relative to cholesterol production in the body. This means that the body is absorbing more cholesterol from dietary sources and potentially converting it into circulating cholesterol. Clinically, this could suggest that a patient's cholesterol levels are more influenced by dietary intake rather than endogenous synthesis.

A low score can guide clinicians in tailoring treatment strategies. For instance, patients with a low Cholesterol Balance Score might benefit more from dietary interventions and medications that reduce cholesterol absorption, such as ezetimibe, rather than those primarily targeting cholesterol production, like statins. Understanding a patient's Cholesterol Balance Score can thus help in developing a personalized approach to managing and reducing cardiovascular disease risk.

The Cholesterol Balance Score, a key marker on the Boston Heart Cholesterol Balance® test, provides a comprehensive assessment of an individual's cholesterol metabolism by evaluating the ratio of cholesterol production to absorption. This score is derived from the direct measurement of lathosterol and desmosterol (cholesterol production markers) and beta-sitosterol, campesterol, and cholestanol (cholesterol absorption markers). By offering insights into both production and absorption pathways, the Cholesterol Balance Score helps clinicians understand the underlying causes of dyslipidemia and tailor treatment strategies more effectively. This personalized approach can enhance the management of cardiovascular disease risk and improve patient outcomes by precisely targeting LDL-C lowering therapies.